David Kurtz, MD, PhD
Chief Medical Officer, Head of Research, Founder
David Kurtz is the Chief Medical Officer, Head of Research, and a cofounder of Foresight Diagnostics. His research focuses on developing and translating methods to detect, monitor, and treat hematologic malignancies. To accomplish this, he works at the intersection of molecular biology, cancer genomics, and bioengineering to develop the next generation of cancer diagnostics. Along with Dr. Ash Alizadeh, David was one of the earliest investigators to explore the utility of tumor-derived cell-free DNA in lymphomas. He has applied multiple methodologies to the detection of cell-free DNA in lymphomas, with a focus on improving the clinical utility and analytical sensitivity of these methods. Clinically, David is a medical oncologist who specializes in the treatment of non-Hodgkin lymphoma. His research program also focuses on the clinical translation of NGS tools and computational approaches for improving care for patients with all types of cancer.
